• Mon news: Autolus enters CAR-T race with FDA approval. FDA clears clinical hold on Novavax. AbbVie schizophrenia trial failure. Cigna not pursuing Humana. GSK leaving BIO. See more on our front page

Eisai wraps filing for Biogen-partnered Aduhelm follow-up, hoping to regain 'credibility and trust'